AZD-1305

CAS No. 872045-91-5

AZD-1305 ( AZD1305 )

Catalog No. M16340 CAS No. 872045-91-5

AZD-1305 is a novel antiarrhythmic agent that predominantly blocks the rapid component of Ikr.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 477 Get Quote
10MG 689 Get Quote
25MG 1062 Get Quote
50MG 1431 Get Quote
100MG 1935 Get Quote
500MG 3861 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AZD-1305
  • Note
    Research use only, not for human use.
  • Brief Description
    AZD-1305 is a novel antiarrhythmic agent that predominantly blocks the rapid component of Ikr.
  • Description
    AZD-1305 is a novel antiarrhythmic agent that predominantly blocks the rapid component of IKr, the L-type calcium current, and the inward sodium current in mammalian cells and ventricular cardiomyocytes; significantly prolongs action potential duration and reduces excitability at 0.1-10 uM in dogs, effectively prevents induction of persistent acetylcholine-mediated atrial fibrillation (AF) in vivo.Heart Arrhythmia Phase 1 Discontinued
  • Synonyms
    AZD1305
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    Cardiovascular Disease
  • Indication
    Heart Arrhythmia

Chemical Information

  • CAS Number
    872045-91-5
  • Formula Weight
    434.51
  • Molecular Formula
    C22H31FN4O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(C)OC(=O)NCCN1C[C@@H]2CN(C[C@H](C1)O2)CCOc3ccc(cc3F)C#N
  • Chemical Name
    (2-(7-(2-(4-Cyano-2-fluorophenoxy)ethyl)-9-oxa-3,7-diazabicyclo(3.3.1)non-3-yl)ethyl)carbamic acid tert-butyl ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sicouri S, et al. J Pharmacol Exp Ther. 2010 Jul;334(1):255-9.
2. Burashnikov A, et al. J Cardiovasc Pharmacol. 2010 Jul;56(1):80-90.
3. Johnson DM, et al. Circ Arrhythm Electrophysiol. 2012 Feb;5(1):201-9.
4. Geller JC, et al. J Clin Pharmacol. 2009 Mar;49(3):312-22.
molnova catalog
related products
  • Ranolazine dihydroch...

    An anti-ischemic agent that has been shown to inhibit late I(Na) and I(Kr) and to have antiarrhythmic effects in various preclinical in vitro models.

  • Levobupivacaine

    Levobupivacaine is an amino-amide local anaesthetic drug belonging to the family of n-alkylsubstituted pipecoloxylidide.

  • Phenytoin sodium

    Phenytoin sodium is an inactive voltage-gated sodium channel stabilizer.